Status:

UNKNOWN

Nutrition, gUT Microbiota, and BRain AgINg: the NutBrain Study

Lead Sponsor:

IRCCS National Neurological Institute "C. Mondino" Foundation

Collaborating Sponsors:

Institute of Biomedical Technologies-National Research Council (ITB-CNR)

Conditions:

Cognitive Dysfunction

Dietary Habits

Eligibility:

All Genders

65+ years

Brief Summary

Epidemiological evidence suggests that healthy diet is associated with a slowdown of cognitive decline leading to dementia, but the underlying mechanisms are still partially unexplored. Diet is the ma...

Detailed Description

The NutBrain Study aims to understand the biological mechanisms through which diet influences cognitive disorders with a special focus on the impact of nutrition on gut microbiota and brain characteri...

Eligibility Criteria

Inclusion

  • attending a medical appointment in the research facility
  • living at home in one of the two municipalities
  • being 65+ years

Exclusion

  • i) neuropsychological criteria:
  • subject with dementia, pre-existing cognitive impairment (e.g. aphasia, neglect), concomitant severe psychiatric disease, others neurological conditions (e.g. severe depression and behavioral disorders)
  • severe sensory disturbances (e.g. auditory and/or visual loss) that do not allow completing neuropsychological assessment
  • ii) microbiota' analysis protocol:
  • individuals with artificial nutrition in progress
  • history of active uncontrolled gastrointestinal disorders or diseases (inflammatory bowel disease, ulcerative colitis, and Crohn's disease)
  • subjects who underwent previous major surgery on the gastro-enteric tract, with the exception of cholecystectomy and appendectomy, in the past five years
  • use of antibiotics or large doses of commercial probiotics in the 4 weeks prior the visit
  • subjects under radio-chemo-therapy
  • iii) MRI scanning protocol:
  • subjects with metal fragments in the body, surgically implanted devices containing metal
  • severe claustrophobia
  • inability to lie down in the MRI scanner for the duration of the study

Key Trial Info

Start Date :

April 1 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 1 2022

Estimated Enrollment :

643 Patients enrolled

Trial Details

Trial ID

NCT04461951

Start Date

April 1 2019

End Date

April 1 2022

Last Update

July 8 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Struttura Semplice Neuropsicologia Clinica/ Centro UVA

Pavia, Italy, 27100